— T-Mobile US Inc. (NASDAQ: TMUS) reported its third-quarter 2019 earnings of $1.01 per share versus $0.96 per share expected.
— Total revenues rose by 2% to $11.1 billion versus $11.33 billion expected. The results were driven by growth in service revenues partially offset by a decline in equipment revenues primarily due to a decrease in the number of devices sold.
— Total net customer additions increased by 7% to 1.75 million. Total customers at the end of the period increased by 9% to 84.18 million.
— Branded postpaid net additions declined by 0.5% to 1.07 million. Branded postpaid net additions fell by 3% to 754,000. Branded postpaid phone churn fell to 0.89% from 1.02% a year ago.
— Branded prepaid net additions jumped by 77% to 62,000. Branded prepaid churn dropped to 3.98% from 4.12% a year earlier.
— For 2019, the company lifted postpaid net customer additions outlook to the range of 4.1 to 4.3 million from the previous estimates range of 3.5 to 4 million.
— Adjusted EBITDA is now expected to be in the range of $13.1 billion to $13.3 billion, up from the previous forecast range of $12.9 billion to $13.3 billion in 2019.
Read: AT&T Q3 earnings review
— In Q4 2019, pre-close merger-related costs are expected to be $125 million to $150 million before taxes.
— T-Mobile will launch its nationwide 5G network in 2019 in conjunction with the introduction of the first compatible 5G smartphones, including OnePlus 7T Pro 5G McLaren.
— At the end of Q3, T-Mobile owned a nationwide average of 31 MHz of 600 MHz low band spectrum. As of September 30, 2019, the company had cleared 231 million POPs and expects to clear spectrum covering about 275 million POPs by year-end.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company